Stay updated on Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the Lanadelumab in HAE Clinical Trial page.

Latest updates to the Lanadelumab in HAE Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedSummary of changes: added a government funding notice with current operating status guidance and updated version to v3.2.0; removed the old version label v3.1.0.SummaryDifference12%
- Check22 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1), and the Back to Top element has been removed.SummaryDifference0.7%
- Check44 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.7%
- Check51 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several location-related terms have been removed.SummaryDifference15%
- Check65 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.3%
Stay in the know with updates to Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lanadelumab in HAE Clinical Trial page.